High-Density Speckle Contrast Optical Tomography (HD-SCOT) is an optical technique with the potential to address the limitations of current techniques for imaging Cerebral Blood Flow (CBF). To evaluate HD-SCOT’s performance, we developed an anatomical-head-based simulation to obtain HD-SCOT measurements and reconstructed images. We observed that including longer source-detector distances can reduce localization errors. Even though speckle contrast decreases with increased exposure times, the System-to-Noise Ratio (SNR) can increase dramatically. For instrumentation, we evaluated statistics of speckles through a multi-mode fiber (MMF) bundle and demonstrated the feasibility of tracking pulsatile blood flow in a human subject using MMFs.
High-density speckle contrast optical tomography (HD-SCOT) is a potentially attractive technique for bedside imaging of cerebral blood flow (CBF). To evaluate the performance of HD-SCOT, we built a pipeline with an anatomical head model for simulating measurements and reconstructed images. We observed that the cortical region is well represented by measurements with source-detector distance at least 29 mm. Including larger source-detector distances can reduce localization errors but with reduced signal-to-noise ratio (SNR). Imaging performance is highly dependent on the exposure time, with optimal exposure time dependent on the noise model. Future HD-SCOT systems will be designed using these results.
Speckle contrast optical spectroscopy/tomography (SCOS/SCOT) is a low-cost, non-invasive, and real-time optical imaging modality for measuring cerebral blood flow with increased signal-to-noise ratio relative to diffuse correlation spectroscopy. However, the recent camera-based detector system is not ideal for imaging a large area of the human brain because of the limited area of focus over the contour of the head and hair occluding the field of view. Here we demonstrated the feasibility of using inexpensive multi-mode fiber bundles to build a SCOS system for mapping the flow of fluids, and we showed a statistical method for distinguishing noise and speckle signals.
High-density speckle contrast optical tomography (HD-SCOT) is attractive for imaging cerebral blood flow (CBF), with desirable cost and signal-to-noise ratio (SNR). Previous studies showed feasibility of HD-SCOT in rodent models using lab instruments. To investigate potential performance for a dedicated HD-SCOT instrument, we simulated HD-SCOT imaging for an anatomical head model. We evaluated potential imaging performance versus depth for varying exposure times and measurement availability. Results showed that an HD-SCOT system could have image resolution of 13 mm full-width-half-maximum at 12 mm depth, with instrument parameters affecting localization error and SNR. These results will guide design of future research instruments
Tumors in the central nervous system (CNS) can produce significant behavior deficits. These deficits significantly reduce the quality of life of long-term brain tumor survivors. Motor deficits can be the main presenting symptoms that brings a brain tumor patient into the hospital. Additionally, motor deficits can either improve or worsen after treatment. Its poorly understood how tumor phenotype (e.g infiltrative or circumscribed) contributes to the development and evolution of motor deficits. Resting state functional connectivity magnetic resonance imaging (rsfc-MRI) could help determine a relationship between brain function and tumor phenotype. rsfc-MRI provides measurements of functional connectivity (FC), which is a measure of brain activity and has been shown to correlate with neurological function (e.g. cognitive and motor deficit) in many disease states. Additional studies are needed before rsfc-MRI can be included in the standard of care for brain tumor patients because it is largely unknown how important clinical factors, such as tumor location and tumor burden (e.g. tumor volume), modulate the association between FC measurements and neurological performance. However, human studies are unlikely to have the statistical power to determine the relationships between FC, clinical factors, and neurological function because it is difficult to enroll many human subjects while controlling for a factor. Fortunately, mice can be used to control for a factor in many genetically identical specimens. Therefore, FC assessments need to be applied to studies in mouse models of brain tumors to assess the interactions be specific clinical factors, FC measurements and neurological function. FC measurements are infrequently obtained in mouse models because it is technically difficult to perform rsfc-MRI on the small mouse brain. Fortunately, functional connectivity optical intrinsic signal imaging (fcOISI) can be used obtain FC measurements in mice. In this study, we investigated how tumor phenotype modulates the relationship between tumor burden measures and motor function. We injected in two groups of mice with human brain tumor cell lines that exhibit different growth phenotypes. We assessed the motor function of the mice by their performance on a battery of sensorimotor tests. We determined tumor burden with bioluminescence and MRI and assessed FC with fcOISI. Lastly, we performed linear regression analysis to determine how these measured factors interact in the prediction of performance on the motor tests.
Gliomas are known to cause significant changes in normal brain function that lead to cognitive deficits. Disruptions in resting state networks (RSNs) are thought to underlie these changes. However, investigating the effects of glioma growth on RSNs in humans is complicated by the heterogeneity in lesion size, type, and location across subjects. In this study, we evaluated the effects of tumor growth on RSNs over time in a controlled mouse model of glioma growth. Methods: Glioma cells (5x104-105 U87s) were stereotactically injected into the forepaw somatosensory cortex of adult nude mice (n=5). Disruptions in RSNs were evaluated weekly with functional connectivity optical intrinsic signal imaging (fcOIS). Tumor growth was monitored with MRI and weekly bioluminescence imaging (BLI). In order to characterize how tumor growth affected different RSNs over time, we calculated a number of functional connectivity (fc) metrics, including homotopic (bilateral) connectivity, spatial similarity, and node degree. Results: Deficits in fc initiate near the lesion, and over a period of several weeks, extend more globally. The reductions in spatial similarity were found to strongly correlate with the BLI signal indicating that increased tumor size is associated with increased RSN disruption. Conclusions: We have shown that fcOIS is capable of detecting alterations in mouse RSNs due to brain tumor growth. A better understanding of how RSN disruption contributes to the development of cognitive deficits in brain tumor patients may lead to better patient risk stratification and consequently improved cognitive outcomes.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.